Pharmacodynamics News and Research

RSS
Alnylam submits CTA application to MHRA to initiate Phase 1/2 study of ALN-AAT02

Alnylam submits CTA application to MHRA to initiate Phase 1/2 study of ALN-AAT02

Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI

Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI

Alector announces initiation of Phase 1 trial of AL001 for treating frontotemporal dementia

Alector announces initiation of Phase 1 trial of AL001 for treating frontotemporal dementia

Experts describe role of quantitative systems pharmacology in first-in-human clinical trials

Experts describe role of quantitative systems pharmacology in first-in-human clinical trials

Alexo Therapeutics marks next significant milestone by initiating ALX148 combination cohorts

Alexo Therapeutics marks next significant milestone by initiating ALX148 combination cohorts

Aravive Biologics demonstrates proof-of-mechanism for AVB-S6-500 in ongoing phase 1 study

Aravive Biologics demonstrates proof-of-mechanism for AVB-S6-500 in ongoing phase 1 study

KU Cancer Center to present evidence supporting anti-cancer drug at AACR 2018

KU Cancer Center to present evidence supporting anti-cancer drug at AACR 2018

New antifungal drug developed to help in treatment of invasive fungal infections

New antifungal drug developed to help in treatment of invasive fungal infections

FDA grants approval for new biosimilar to treat multiple types of cancer

FDA grants approval for new biosimilar to treat multiple types of cancer

Study finds link between upper GI infections and protein implicated in Parkinson’s disease

Study finds link between upper GI infections and protein implicated in Parkinson’s disease

Antibiotic resistance: a healthcare emergency?

Antibiotic resistance: a healthcare emergency?

New position paper recommends sex-specific cardiovascular drug dosages for better treatment

New position paper recommends sex-specific cardiovascular drug dosages for better treatment

Study identifies urinary biomarker that may help monitor progression of ALS

Study identifies urinary biomarker that may help monitor progression of ALS

University of Liverpool to establish new research centre to accelerate development of novel antibiotics

University of Liverpool to establish new research centre to accelerate development of novel antibiotics

Ardelyx initiates two clinical trials to evaluate new treatment for hyperkalemia

Ardelyx initiates two clinical trials to evaluate new treatment for hyperkalemia

Two research studies on new molecules could potentially treat Alzheimer's disease

Two research studies on new molecules could potentially treat Alzheimer's disease

Combined endocrine and targeted therapy could be effective in treating Asian breast cancer patients

Combined endocrine and targeted therapy could be effective in treating Asian breast cancer patients

Getting drugs to bugs in NTM lung infections: an interview with Dr Jakko van Ingen

Getting drugs to bugs in NTM lung infections: an interview with Dr Jakko van Ingen

FDA approves new biosimilar for multiple inflammatory diseases

FDA approves new biosimilar for multiple inflammatory diseases

Novel anti-interleukin 1-alpha antibody shows promise in treating advanced colorectal cancer patients

Novel anti-interleukin 1-alpha antibody shows promise in treating advanced colorectal cancer patients